Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyoti Batra

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|August 8, 2025
Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signalingGrace Uwase, Priya Luthra, Olivia A Vogel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signalingGrace Uwase, Priya Luthra, Olivia A Vogel, et al.
The EMBO Journal|July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infectionJyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
Plos Pathogens|April 20, 2026
Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cellsSégolène Gracias, Elodie Le Seac'h, Samuel Donaire-Carpio, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Regulation of virion production by the ORF8 signal peptide across SARS-CoV-2 variantsMir M Khalid, Irene Chen, Frank S Soveg, et al.
Cell|December 15, 2018
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus ReplicationJyoti Batra, Judd F Hultquist, Dandan Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M White, Romel Rosales, Soner Yildiz, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variantLucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature|March 25, 2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature|December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|August 8, 2025
Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signalingGrace Uwase, Priya Luthra, Olivia A Vogel, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025
Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signalingGrace Uwase, Priya Luthra, Olivia A Vogel, et al.
The EMBO Journal|July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infectionJyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
Plos Pathogens|April 20, 2026
Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cellsSégolène Gracias, Elodie Le Seac'h, Samuel Donaire-Carpio, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Regulation of virion production by the ORF8 signal peptide across SARS-CoV-2 variantsMir M Khalid, Irene Chen, Frank S Soveg, et al.
Cell|December 15, 2018
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus ReplicationJyoti Batra, Judd F Hultquist, Dandan Liu, et al.
Science (New York, N.Y.)|January 26, 2021
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M White, Romel Rosales, Soner Yildiz, et al.
Biorxiv : the Preprint Server for Biology|June 15, 2021
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variantLucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature|March 25, 2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Nature|December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Pageof 6